Pulmonary Disorders and COVID-19

Jump to navigation Jump to search

To go to the COVID-19 project topics list, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Overview

Complications

Acute respiratory distress syndrome

Pneumonia

Pulmonary embolism

Hypoxemia

Superinfection

Respiratory failure

Increased mortality in COPD patients

  • According to a study conducted in China, having an underlying comorbidity such as chronic obstructive pulmonary disease (COPD) conferred a mortality hazard ratio of 2.681, even after adjusting for smoking status.[1][2][3][4]

References

  1. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM; et al. (2020). "Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis". Eur Respir J. 55 (5). doi:10.1183/13993003.00547-2020. PMC 7098485 Check |pmc= value (help). PMID 32217650 Check |pmid= value (help).
  2. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184
  3. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184
  4. Ñamendys-Silva SA (2020). "Respiratory support for patients with COVID-19 infection". Lancet Respir Med. 8 (4): e18. doi:10.1016/S2213-2600(20)30110-7. PMC 7129706 Check |pmc= value (help). PMID 32145829 Check |pmid= value (help).